A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial.
Timothy Stopford Christopher HinksVicki S BarberJoanna BlackSusan J DuttonMaisha JabeenJames MelhornNajib M RahmanDuncan RichardsDaniel LassersonIan D PavordMona BafadhelPublished in: Trials (2020)
ClinicalTrials.gov NCT04381962 . Registered on 11 May 2020. EudraCT identifier 2020-001740-26 . Opened for accrual on 29 May 2020.
Keyphrases
- open label
- clinical trial
- phase ii
- phase iii
- study protocol
- coronavirus disease
- sars cov
- phase ii study
- healthcare
- blood pressure
- palliative care
- double blind
- quality improvement
- pain management
- randomized controlled trial
- squamous cell carcinoma
- respiratory syndrome coronavirus
- affordable care act
- placebo controlled